MURRIETA, Calif. - Nov. 25, 2020 - REV.1 Engineering is please to announce the publication of their most recent White Paper, "When Uncertainty Becomes Certain". REV.1 designs and develops advanced, interventional technologies used in the areas of Structural Heart, Interventional Cardiology, Neuromodulation, Drug/Biologics Device Delivery Systems and Artificial Organs.

"Having been in the industry for more than 30 years, this is the first shock to impact the healthcare delivery system, and subsequently, the medical device industry over the past several decades," said Terry Murray, Vice President of Strategic Development at REV.1. "The term unprecedented truly fits."

"The challenge for the medical device industry is to accurately gauge how the pandemic is impacting their particular market segment, and develop strategic contingencies to mitigate the short term damage," added Terry. "Our White Paper explores how the fallout of this disruption is effecting various segments differently, and how companies can position themselves for a healthy rebound in 2021."

© 2020, REV.1 Engineering®.

Contact
Terrance Murray
terry@rev1engineering.com